Sign in

CIK 0001894525 · <br>Emerging growth company

Apimeds Pharmaceuticals US, Inc.

Sign in to watch
Ticker
APUS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851099700
Phone
848-201-5010
Business address
100 MATAWAN RD, SUITE 325, MATAWAN, NJ, 07747
  1. S-1 Offering Registration Statement
  2. DRS/A Other Draft Registration Statement
  3. DRSLTR Other Correspondence Related to Draft Registration Statement
  4. DRS/A Other Draft Registration Statement
  5. DRSLTR Other Correspondence Related to Draft Registration Statement
  6. UPLOAD Other SEC-generated Letter
  7. DRSLTR Other Correspondence Related to Draft Registration Statement
  8. DRS/A Other Draft Registration Statement
  9. UPLOAD Other SEC-generated Letter
  10. DRS Other Draft Registration Statement

Page 7 of 7 · 130 filings